These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Kassa and others said Big Pharma continues to invest even as private equity funds have pulled back. He noted ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Fidelity Select Biotechnology Portfolio earns an Above ... the industry's flows and money has gushed from actively managed products—Fidelity's included—the firm has continued to grow its ...

If these times have anything to say about it, the next Microsoft is coming from the biotech sector. Investors are moving in looking for profits, even putting companies without products on the map.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its CEO, Steve ...

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded ...

The interface between marine chemistry and marine biology, ranging from natural products chemistry and biotechnology to biogeochemistry and biochemistry relating to marine systems. Many of our ...

Anbio Biotechnology (NNNN) has filed to raise $8.8 million in an IPO of its Class A ordinary shares, according to an SEC F-1 registration statement. NNNN provides in vitro diagnostics products for ...